A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma

The efficacy of anti‐angiogenic treatment by targeting VEGF/VEGF receptors in metastatic clear cell renal cell carcinoma (ccRCC) varies from patient to patient. Discovering the reasons behind this variability could lead to the identification of relevant therapeutic targets. Thus, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Montemagno, Christopher, Durivault, Jérôme, Gastaldi, Cécile, Dufies, Maeva, Vial, Valérie, He, Xingkang, Ambrosetti, Damien, Kamenskaya, Anna, Negrier, Sylvie, Bernhard, Jean‐Christophe, Borchiellini, Delphine, Cao, Yihai, Pagès, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323879/
https://www.ncbi.nlm.nih.gov/pubmed/36810959
http://dx.doi.org/10.1002/1878-0261.13401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323879/
https://www.ncbi.nlm.nih.gov/pubmed/36810959
http://dx.doi.org/10.1002/1878-0261.13401

Ejemplares similares